Penn Medicine Provider
Dermatology
David J. Margolis, MD, PhD
4.8
(252)
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Schedule onlineCall 215-662-2737

About me

  • Director, Cutaneous Ulcer Program
  • Gerald R. Lazarus Professor
  • Professor of Dermatology in Biostatistics and Epidemiology

Education and training

  • Medical School: University of Chicago
  • Residency: Hospital of the University of Pennsylvania

What my patients think about me

Average Rating
4.8

253 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
he's great!
April 2025
5.0
5.0
treated medical concern
April 2025
5.0
5.0
knowledge experience recognized my problems' impacts on me.
April 2025
5.0
5.0
i highly recommend dr. david margolis!

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Margolis is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Palepu S, Sindgi VM, Aylur KS, Margolis DJ, Kovarik C. Mental Health and Substance Use Amongst Trans Women in India , J Homosex: 2025

Grice EA, Brennan-Crispi D, Rodriguez N, Margolis DJ, Seykora JT, Cotsarelis G, Taylor SC, Shuda J. Penn Academy for Skin Health (PASH): An Experiential Pipeline Program in Skin Biology and Dermatology for High-School Students , J Invest Dermatol, 145(3): 2025,478-480

Bibineyshvili Y, Vajtay TJ, Salsabilian S, Fliss N, Suvarnakar A, Fang J, Teng S, Alder J, Najafizadeh L, Margolis DJ. Imaging the large-scale and cellular response to focal traumatic brain injury in mouse neocortex , Exp Physiol, 110(2): 2025,321-344

Barbieri JS, Ellenberg S, Grice E, Tierney A, VanderBeek SB, Papadopoulos M, Mason J, Mason A, Dattilo J, Margolis DJ. Challenges in designing a randomized, double-blind noninferiority trial for treatment of acne: The SD-ACNE trial , Clin Trials, 22(1): 2025,66-76

Lydecker AD, Kim JJ, Robinson GL, Johnson JK, Brown CH, Petruccelli CC, Terrin ML, Margolis DJ, Roghmann MC. Chlorhexidine vs Routine Foot Washing to Prevent Diabetic Foot Ulcers: A Randomized Clinical Trial , JAMA Netw Open, 8(2): 2025,e2460087

Nouri Z, Biglari S, Tabatabaiefar MA, Vahidnezhad F, Hozhabrpour A, March ME, Margolis DJ, Gudjonsson JE, Hakonarson H, Vahidnezhad H. Filaggrinopathies-FLG/FLG2: Diagnostic Complexities and Immunotherapy , J Invest Dermatol: 2025

Barbieri JS, Ellenberg SS, Tierney A, VanderBeek SB, Papadopoulos M, Mason J, Mason A, Dattilo J, Margolis DJ. Establishing minimally important difference thresholds for lesion counts in acne clinical studies , J Am Acad Dermatol: 2025

Wong JJ, Margolis DJ. Association Between Food Allergy Status and Atopic Dermatitis Control and Persistence: A Longitudinal Analysis of the Pediatric Eczema Elective Registry , Pediatr Dermatol: 2024

Chiesa Fuxench ZC, Mitra N, Grice E, Hoffstad O, Margolis DJ. Is seborrhoeic dermatitis of infancy and childhood related to maternal history of seborrhoeic dermatitis? A large population-based cohort study from the UK , Br J Dermatol, 192(1): 2024,72-77

Rosenthal BE, Schaubel DE, Lewis JD, Margolis DJ, Goldberg DS, Bittermann T. Immunosuppression regimen and latitude impact keratinocyte carcinoma risk in U.S. liver transplant recipients , Arch Dermatol Res, 316(9): 2024,641

View all publications